Table 1.
Baseline characteristics of 454 SKCM patients included in this study.
| Variables | Number (%) |
|---|---|
| Vital status | |
| Alive | 214 (47.14) |
| Dead | 240 (52.86) |
| Age (year) | |
| ≤65 | 292 (64.32) |
| >65 | 162 (35.68) |
| Gender | |
| Female | 173 (38.11) |
| Male | 281 (61.89) |
| AJCC-T | |
| T0 | 23 (5.07) |
| T1 | 42 (9.25) |
| T2 | 76 (16.74) |
| T3 | 89 (19.60) |
| T4 | 152 (33.48) |
| Unknown | 72 (15.86) |
| AJCC-N | |
| N0 | 223 (49.12) |
| N1 | 73 (16.08) |
| N2 | 49 (10.79) |
| N3 | 55 (12.12) |
| Unknown | 54 (11.89) |
| AJCC-M | |
| M0 | 405 (89.21) |
| M1 | 23 (5.07) |
| Unknown | 26 (5.72) |
| Stage | |
| I & II | 226 (49.78) |
| III & IV | 192 (42.29) |
| Unknown | 36 (7.93) |
SKCM, skin cutaneous melanoma; AJCC, American Joint Committee for Cancer; T, tumor; N, regional lymph node; M, metastasis.